{"id":"W2590126529","doi":"10.1200/jco.2011.29.15_suppl.4031","title":"Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with. G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC).","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gemcitabine; Neutropenia; Internal medicine; Clinical endpoint; Population; Gastroenterology; Immunohistochemistry; Phases of clinical research; Pancreatic cancer; Adverse effect; Cancer; Surgery; Randomized controlled trial; Clinical trial; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00140373,0.001732077,0.002011768,0.0004557341,0.0003557822,0.0009394868,0.0008156843,0.001269509,0.004998977],"category_scores_gemma":[0.0007121161,0.0005729811,0.00117389,0.0005830814,0.001278241,0.0008569044,0.0005361197,0.002065991,0.001003937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008435984,"about_ca_system_score_gemma":0.001615149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001048914,"about_ca_topic_score_gemma":0.003309409,"domain_scores_codex":[0.9995616,0.0002700482,0.00001532368,0.00007514608,0.00001547507,0.00006237272],"domain_scores_gemma":[0.9993703,0.00009851616,0.0001352582,0.00004005549,0.00002594507,0.0003299789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9680071,0.009203913,0.002189942,0.0003786482,0.0005769736,0.00004845112,0.00003993257,0.000435469,0.004398309,0.00007746899,0.001379796,0.01326403],"study_design_scores_gemma":[0.8782274,0.1151356,0.004622601,0.00002091099,0.0003340734,0.00005226898,0.00002559001,0.0002361343,0.0004307134,0.00009365733,0.0008103075,0.00001088606],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889565,0.002661706,0.0004399868,0.0007072809,0.0002405632,0.003000685,0.001628116,0.0001629922,0.002202061],"genre_scores_gemma":[0.9851381,0.001847875,0.001851316,0.002202628,0.0003613729,0.003207805,0.003140349,0.00004907981,0.002201431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004998977,"threshold_uncertainty_score":0.01672328,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2960620660347831,"score_gpt":0.5318115390963654,"score_spread":0.2357494730615822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}